ArticleIntensive care medicine experimental2026
In vivo mitochondrial oxygen consumption during LPS-induced endotoxemia: a controlled experimental study in swine.
Article in Intensive care medicine experimental, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundSepsis and septic shock are life-threatening syndromes characterized by complex systemic effects, including alterations in tissue oxygenation, mitochondrial function, and organ performance. Despite advances in supportive care, management remains challenging and is largely focused on maintaining adequate perfusion through fluids and vasoactive agents. To better characterize early systemic responses to endotoxemia under different hemodynamic conditions, this study used a swine lipopolysaccharide (LPS)-induced endotoxemia model with graded hypotension exposure. Animals were allocated to a control group (MAP maintained > 80 mmHg) and two LPS-groups defined by different MAP thresholds for initiating hemodynamic support (LPS-1: <80 mmHg; LPS-2: <65 mmHg), with a focus on early mitochondrial and microcirculatory (dys)function.
resultsLPS administration induced marked systemic responses, including tachycardia, metabolic stress, and organ dysfunction. Microcirculatory alterations were present but quantitatively modest. In vivo mitochondrial oxygen tension (mitoPO
conclusionEarly LPS-induced endotoxemia was associated with reduced or blunted mitoVO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.